Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early treatment of acute migraine with rizatriptan ODT vs placebo
2007-003361-40Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in migraine comparing Rizatriptan ODT arm with Placebo arm (2 arms). Primary endpoint: Pain freedom at 2 hours post-dose. Started Jul 2008; status: completed.
02
Drugs
rizatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on 2007-003361-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003361-40.